Albert Bourla: 2025 was a very good year for Pfizer Inc. I'm very pleased with strong execution to deliver and, frankly, overdeliver on our financial commitments. If successful, we will substantially ...
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 2b VESPER-3 study investigating monthly maintenance dosing of its fully-biased, ultra-long-acting, injectable GLP-1 ...
Delivered Year-over-Year Improvement in Profitability While Investing in Ambitious Innovation Agenda Raises Full Year FY2026 Adjusted EBITDA ...
Current secondary dataset show that the UAE leads the world in millionaires, with a significant number of HNWIs migrating to ...
This paper presents a novel framework for optimizing Carbon Release (CR) through an AI-driven approach to Fossil Fuel Intake (FFI) management. We propose a new training methodology for AI models to ...